Moderate Evidence
Research Overview
Cortexin Research for Stroke Recovery
An evidence-based overview of research examining Cortexin in the context of stroke recovery. This page synthesizes findings from peer-reviewed literature.
Research Summary
Cortexin has been studied in Russia for post-stroke recovery. Animal studies demonstrate neuroprotective effects in ischemia models (Kurkin et al., 2021). Russian clinical trials report improvements in neurological outcomes, though these lack independent Western validation. No FDA-approved indications exist.
Referenced Studies
Click any PMID to view the full study on PubMed.
Important Disclaimer
This page summarizes research findings and does not constitute medical advice. Always consult a healthcare provider before making health decisions.